AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2014
Jan 27, 2014
34395_dirs_2014-01-27_a5d28f08-4c1d-45ed-90e7-f7c9b9eacf66.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2013-12-31
Reporting Person: Faulkes Martin Charles (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 926067 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrant | $1.05 | 2016-07-13 | Common Stock (250000) | 250000 | Direct |
| Option | $3 | 2015-05-25 | Common Stock (5000) | 5000 | Direct |
| Option | $3 | 2015-11-25 | Common Stock (5000) | 5000 | Direct |
| Option | $4 | 2016-05-25 | Common Stock (5000) | 5000 | Direct |
| Option | $4 | 2016-11-25 | Common Stock (5000) | 5000 | Direct |
| Option | $5 | 2017-05-25 | Common Stock (5000) | 5000 | Direct |
| Option | $5 | 2017-11-25 | Common Stock (5000) | 5000 | Direct |
| Warrant | $2.6 | 2016-05-10 | Common Stock (58034) | 58034 | Direct |
More from VOLITIONRX LTD
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 1